000137001 001__ 137001
000137001 005__ 20240229105110.0
000137001 0247_ $$2doi$$a10.1016/j.msard.2018.06.008
000137001 0247_ $$2pmid$$apmid:29982111
000137001 0247_ $$2ISSN$$a2211-0348
000137001 0247_ $$2ISSN$$a2211-0356
000137001 0247_ $$2altmetric$$aaltmetric:44763350
000137001 037__ $$aDKFZ-2018-01429
000137001 041__ $$aeng
000137001 082__ $$a610
000137001 1001_ $$aNegaresh, Raoof$$b0
000137001 245__ $$aEffects of exercise training on cytokines and adipokines in multiple Sclerosis: A systematic review.
000137001 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2018
000137001 3367_ $$2DRIVER$$aarticle
000137001 3367_ $$2DataCite$$aOutput Types/Journal article
000137001 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1537173809_32596$$xReview Article
000137001 3367_ $$2BibTeX$$aARTICLE
000137001 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000137001 3367_ $$00$$2EndNote$$aJournal Article
000137001 520__ $$aPhysical activity, particularly exercise training, is an evidence-based approach for managing symptoms, restoring function and improving overall wellness in people with multiple sclerosis (MS). Several recent studies have argued for a potential disease modifying effect of exercise in people with MS, and among the potential mediating mechanisms are exercise training effects on both cytokines and adipokines. The objectives of this study were to perform a systematic review of exercise training effects on cytokine and adipokine profiles in persons with MS.We conducted open-dated searches of PubMed, Cochrane Library, EMBASE and PEDro using the terms Multiple sclerosis or MS AND exercise OR training OR physical activity AND cytokine OR inflammatory OR immune OR adipokine. Included studies were written in English; comprised of humans with MS, and evaluated the effects of regular physical activity or exercise on pro-inflammatory, anti-inflammatory cytokines or adipokines. Two authors independently scanned titles and abstracts, and read the studies included. All studies were rated on the PEDro scale and further classified based on American Academy of Neurology criteria.Twelve studies were included of which 10 studies focused on cytokines, 1 study focused on adipokines, and 1 study included both cytokines and adipokines. The selected studies included 3 Class I studies, 7 Class II studies, and 2 Class IV studies and had average PEDro scores of 6.9 ± 1.6. Studies included endurance (n = 5), resistance (n = 3), combined (n = 3), and vibration (n = 1) training. Overall, there is a general lack of standardization of procedures across studies and inconsistent evidence for the effects of physical activity and exercise on cytokine and adipokine profiles in MS, with a general pattern indicating a lack of effect.Research regarding the effects of exercise training on cytokines and adipokines in MS is in its infancy, but exercise represents an adjuvant therapy in MS, and future studies are essential for clarifying the role of exercise on cytokines and adipokines in MS.
000137001 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000137001 588__ $$aDataset connected to CrossRef, PubMed,
000137001 7001_ $$aMotl, Robert W$$b1
000137001 7001_ $$aMokhtarzade, Motahare$$b2
000137001 7001_ $$aDalgas, Ulrik$$b3
000137001 7001_ $$aPatel, Darpan$$b4
000137001 7001_ $$aShamsi, Mehdieh Molanouri$$b5
000137001 7001_ $$aMajdinasab, Nastaran$$b6
000137001 7001_ $$aRanjbar, Rouholah$$b7
000137001 7001_ $$0P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aZimmer, Philipp$$b8$$udkfz
000137001 7001_ $$0P:(DE-HGF)0$$aBaker, Julien S$$b9$$eLast author
000137001 773__ $$0PERI:(DE-600)2645330-7$$a10.1016/j.msard.2018.06.008$$gVol. 24, p. 91 - 100$$p91 - 100$$tMultiple Sclerosis and Related Disorders$$v24$$x2211-0348$$y2018
000137001 909CO $$ooai:inrepo02.dkfz.de:137001$$pVDB
000137001 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000137001 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000137001 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000137001 9141_ $$y2018
000137001 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000137001 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMULT SCLER RELAT DIS : 2015
000137001 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000137001 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000137001 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000137001 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000137001 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000137001 9201_ $$0I:(DE-He78)G210-20160331$$kG210$$lBewegung, Präventionsforschung und Krebs$$x0
000137001 980__ $$ajournal
000137001 980__ $$aVDB
000137001 980__ $$aI:(DE-He78)G210-20160331
000137001 980__ $$aUNRESTRICTED